Colitis - 174 Studies Found

Completed : Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
: Ulcerative Colitis
: 2012-08-23
Recruiting : Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis
: Colitis
: 2016-02-16
: Drug: Golimumab (GLM) GLM is a human IgG1κ monoclonal antibody produced by a murine hybridoma cell
Completed : Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
: Ulcerative Colitis
: 2006-03-02
:
  • Drug: COLAL-PRED® COLAL-P
Completed : Rituximab in Active Ulcerative Colitis
: Ulcerative Colitis
: 2005-11-29
: Drug: Rituximab Rituximab 1g in 500 mls Normal Saline Placebo 500 mls Normal Saline
Completed : A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
: Ulcerative Colitis
: 2009-02-27
:
  • Biological: adalimumab Other N
Completed : Budesonide Treatment for Lymphocytic Colitis
: Microscopic Colitis
: 2005-09-09
: Drug: Budesonide
Completed : Basiliximab in Moderate to Severe Ulcerative Colitis
: Ulcerative Colitis
: 2007-01-31
: Drug: Basiliximab 3 doses of 40mg, IV at baseline, week 2, and week 4
Completed : Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
: Ulcerative Colitis
: 2012-06-01
:
  • Drug: ASP3291 Tablet, 1,000 mg
Completed : Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
: Ulcerative Colitis
: 2013-01-17
:
  • Drug: Ciprofloxacin Antibiotic
Completed : Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
: Ulcerative Colitis
: 2007-12-12
: Biological: adalimumab Prefilled syringes 40 mg EOW subcutaneous and prefilled syringes 40 mg weekly sub
<<< Previous | Next >>>